Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
Significant reductions seen in weight, HbA1c, total daily dose of insulin with GLP-1RA, and in HbA1c and basal insulin with SGLTi.
Source: empr.com
Khary Edwards News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Khary Edwards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Khary Edwards Today - Breaking & Trending Today
Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) -- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated hemoglobin A1c (HbA1c), according to a study recently published in the Journal of Clinical Endocrinology & Metabolism. Khary Edwards, M.D., from the University of
Source: physiciansweekly.com
Study provides a rare view of real-world use of off-label drugs prescribed for Type 1 diabetes
Two classes of drugs prescribed off-label for some patients with Type 1 diabetes can provide significant benefits but also come with health concerns, according to a study by UT Southwestern Medical Center researchers.
Source: news-medical.net